About the Presenter Brendan S. Maher is a Professor of Law and the Director of the independently endowed Insurance Law Center at UConn School of Law. A graduate of Stanford University and Harvard Law School, Maher is the faculty advisor for the peer-reviewed Connecticut Insurance Law Journal and a nationally recognized expert in the regulation…
Clinical investigators, public health advocates, and IRBs have been struggling to develop appropriate policies on how to return results to patients involved in research studies. These results may come in a variety of forms, ranging from aggregated study results to individual results to incidental findings. Experts disagree over the optimal timing, how researchers should consider…
Many of today’s important medications are biological products made from living organisms, manufactured through biotechnology, derived from natural sources, or produced synthetically. Biosimilars are a type of biological product approved by FDA on the basis of being highly similar to an already approved biological reference product. This panel of experts discussed the current state of…
The Digital Health @ Harvard brown bag lunch series features speakers from Harvard as well as collaborators and colleagues from other institutions who research the intersection between health and digital technology. The series is cosponsored by the Berkman Klein Center for Internet & Society at Harvard University and the Petrie-Flom Center for Health Law Policy,…
The Fifth Annual Health Law Year in P/Review symposium featured leading experts discussing major developments during 2016 and what to watch out for in 2017. The discussion at this day-long event covered hot topics in such areas as health policy under the new administration, regulatory issues in clinical research, law at the end-of-life, patient rights…
The Petrie-Flom Center hosted a live web panel to address what health care reform might look like under President-elect Trump’s administration. Expert panelists discussed the future of the Affordable Care Act under a “repeal and replace” strategy, alternative approaches to insurance coverage and access to care, the problem of high drug prices, innovation policy, support…
This symposium brought together a variety of experts to discuss key ethical and legal questions regarding offers of payment to research participants. Panels covered: This event was free and open to the public. Agenda 8:00 – 8:30am, Registration 8:30 – 8:40am, Welcome Remarks – Motivation, Open Questions, and Goals 8:40 – 9:40am, Session 1: Why…
In January, the International Committee of Medical Journal Editors proposed requiring that investigators make de-identified trial data available six months after publication as a precondition of consideration. Many data scientists support the policy and champion even more stringent standards as a means to accelerate scientific advances, tackle the problem of irreproducibility, and fulfill moral obligations…
The Animal Law & Policy Program at Harvard Law School hosted The Animal Welfare Act at Fifty, a conference that brought experts together to assess the first fifty years of the Animal Welfare Act (AWA) and consider recommendations for the future. The event included conference presentations as well as a separate academic workshop. This event…
Presentation Topic: “Advanced and End of Life Care: Cautionary Suggestions” This paper is not available for download. To request a copy in preparation for the workshop, please contact Jennifer Minnich at jminnich@law.harvard.edu. About the Presenter Frances Kamm is the Littauer Professor of Philosophy and Public Policy in the Kennedy School of Government and Professor of…
